In the News

Mar 12, 2026

Capricor Therapeutics Announces Positive Data from HOPE-3 Study of Deramiocel

Mar 11, 2026

FDA resumes review of Capricor’s cell therapy deramiocel

Dec 11, 2025

Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial

Dec 9, 2025

New trial results highlight gains in arm and heart function for DMD

Dec 3, 2025

Capricor says its cell therapy improved heart and muscle function in Duchenne patients

Dec 3, 2025

Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy

Dec 3, 2025

Capricor's cell therapy improves muscle, cardiac function in Duchenne study

Oct 11, 2024

Capricor cell therapy improves cardiac and upper limb function in phase 2 Duchenne muscular dystrophy victory lap

Oct 9, 2024

Capricor Submits BLA for Approval of Dermiocel in Treating DMD Cardiomyopathy

May 19, 2022

Watch ABC10 Interview with Dr. Craig McDonald of UC Davis discussing Capricor’s HOPE-3 trial